FDA Adverse Event Injury Summary report: N

EX-PRESS GLAUCOMA FILTRATION DEVICE

MDR report key: 4964315 · Received August 4, 2015

Report

Report Number
3003701944-2015-00616
Event Type
Injury
Date Received
August 4, 2015
Date of Event
July 5, 2013
Report Date
March 15, 2016
Manufacturer
OPTONOL LTD.
Product Code
KYF
PMA / PMN Number
K012852
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4)

Additional Manufacturer Narrative · 1

EVALUATION SUMMARY: THE PRODUCT WAS NOT RETURNED FOR ANALYSIS. THE RESULTS FROM THE PRODUCT HISTORY RECORD REVIEW INDICATED THE PRODUCT MET RELEASE CRITERIA. THE PRODUCT INVESTIGATION COULD NOT IDENTIFY A ROOT CAUSE. THERE HAVE BEEN NO OTHER COMPLAINTS REPORTED IN THE LOT NUMBER. ATTEMPTS HAVE BEEN MADE TO OBTAIN ADDITIONAL INFORMATION. A COMPLETED QUESTIONNAIRE WAS RECEIVED. (B)(4).

Description of Event or Problem · 1

AN OPHTHALMIC SURGEON REPORTED THAT ONE MONTH FOLLOWING A GLAUCOMA FILTRATION DEVICE/CATARACT EXTRACTION WITH INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT'S INTRAOCULAR PRESSURE (IOP) INCREASED. SUTURE LYSIS WAS PERFORMED ON FIVE SEPARATE OCCASIONS. A NEEDLING WAS PERFORMED 6 WEEKS FOLLOWING THE INITIAL SURGERY AND IOP LOWERING TOPICAL MEDICATION WAS ADDED. THE SHUNT WAS REMOVED AND FILTRATION BLEB RECONSTRUCTION WAS PERFORMED.

Description of Event or Problem · 1

ADDITIONAL DETAILS WERE PROVIDED BY THE SURGEON THAT DURING THE SAME PROCEDURE THAT THE DEVICE WAS REMOVED, A TRABECULECTOMY WAS PERFORMED AFTER CONFIRMING THAT THERE WAS NO AQUEOUS HUMOR LEAKAGE. THE SURGEON INDICATED AN INCOMPLETE FUNCTION OF THE DEVICE WAS THE CAUSAL RELATIONSHIP BETWEEN THE EVENT AND THE DEVICE. THE PATIENT IS RECOVERED AS OF FIVE MONTHS FOLLOWING THE INITIAL PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
506639 EX-PRESS GLAUCOMA FILTRATION DEVICE IMPLANT, EYE VALVE KYF OPTONOL LTD. P-50 PL 123033

Patients

Seq Age Sex Outcome Treatment
1 61 YR Other| R LUMIGAN| COSOPT| ALPHAGAN